Inhalation Sedatives Market Produces Generic Drugs As A New Trend In The Industry einnews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from einnews.com Daily Mail and Mail on Sunday newspapers.
hirenFebruary 18, 2021
The report titled “
Global Gastrointestinal Drugs Market Evolving Industry Trends and Key Insights by 2026| ZMR” and published by Zion Market Research (ZMR)is a document that aims at offering a methodical and organized explanation of the important aspects of the global Gastrointestinal Drugs Market. This will further assist the reader in better evaluation of the previous, existing, and future dynamics and situations of the global market. The report entails the market overview along with a detailed analysis of several market players competing and contributing remarkably within the market. The key players comprise:
Allergan Plc., Abbott Laboratories, Bayer AG, AstraZeneca, GlaxoSmithKline Plc., Boehringer Ingelheim GmbH., Sanofi, Janssen Biotech Inc., Valeant Pharmaceuticals Inc., and Takeda Pharmaceutical,. Further, the report encompasses a thorough assessment of the strategies such as research&development, mergers & acquisitions, new product developm
Europe, CIS and Middle East & North Africa Sorbitol Market Report 2020: Market Size is Expected to Reach $568.4 Million by 2027
February 16, 2021 07:03 ET | Source: Research and Markets Research and Markets Dublin, IRELAND
ResearchAndMarkets.com s offering.
The Europe, CIS and Middle East and North Africa Sorbitol market size is expected to reach USD 568.4 million by 2027. It is expected to expand at a CAGR of 3.4% from 2020 to 2027.
Ascending product utilization in the production of a variety of food and beverage products, such as chocolates, candies, and fruit juice, is projected to boost the growth of the market.
Sorbitol is gaining high demand as a useful constituent in dietary foods and beverages, wherein it acts as an effective sugar substitute on account of its low-calorie content. Significant benefits such as reduced calorie value, protection against tooth decay, and usefulness as an alternative to sugar for diabetic
Global Gastroparesis Market and Epidemiology Insights 2017-2030 - Total Prevalence, Type-specific, Gender-specific, Severity-specific, Total Diagnosed
January 22, 2021 04:03 ET | Source: Research and Markets Research and Markets Dublin, IRELAND
Dublin, Jan. 22, 2021 (GLOBE NEWSWIRE) The Gastroparesis - Epidemiology Forecast to 2030 report has been added to
ResearchAndMarkets.com s offering.
Gastroparesis - Epidemiology Forecast to 2030 delivers an in-depth understanding of the disease, historical and forecasted Gastroparesis epidemiology in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan.
Study Period: 2017-2030
Epidemiology Perspective
The disease epidemiology covered in the report provides historical as well as forecasted epidemiology segmented by Total Prevalence of Gastroparesis, Gender-specific Prevalence of Gastroparesis, Severity-specific Prevalence of Gastroparesis, Type-sp